{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:28:56Z","timestamp":1787027336441,"version":"build-2736575974"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background and aim<\/jats:title>\n                    <jats:p>The COVID-19 pandemic caused by SARS-CoV-2 severely affected healthcare globally. Strong links have been suggested between the pandemic and changes in the epidemiology of organisms responsible for non-COVID-19 pneumonia. In this study, we examined temporal changes in organisms recovered from sputum culture, integrating laboratory data from all submitted sputum specimens with clinical data from a subset of patients diagnosed with community-acquired pneumonia (CAP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A retrospective study was conducted from August 2017 to May 2024 using data derived from samples from healthcare centres in Sheffield including hospitals, general practices, hospices and other palliative care settings. August 2017 to March 2020, April 2020 to September 2022, and October 2022 to May 2024 were defined as before, during, and after COVID-19 periods, respectively. Absolute percentage-point change in the distribution of organisms was performed at genera level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 50,827 culture positive isolate episodes from sputum samples were analysed during the study period, of which 25,085 (45.4%; 783.9 isolate episodes per month), 11,644 (22.9%; 388.1 isolate episodes per month) and 14,098 (27.7%; 704.9 isolate episodes per month) were obtained before, during and after COVID-19, respectively. Overall, the commonest cultured genus were\n                      <jats:italic>Haemophilus<\/jats:italic>\n                      sp. (21,229\/50,827, 41.8%),\n                      <jats:italic>Pseudomonas<\/jats:italic>\n                      sp. (5,504\/50827, 10.8%), and\n                      <jats:italic>Streptococcus<\/jats:italic>\n                      sp. (4,893\/50,827, 9.6%).\n                      <jats:italic>Haemophilus<\/jats:italic>\n                      sp. remained the commonest cultured genus in each period of the study.\n                      <jats:italic>Streptococcus<\/jats:italic>\n                      sp. was the second commonest (2,769\/25,085, 11.0%) before COVID-19; fourth commonest (862\/11,644, 7.4%) after\n                      <jats:italic>Pseudomonas<\/jats:italic>\n                      sp. (1,672\/11,644, 14.4%) and Staphylococcus sp. (1,279\/11,644, 11.0%) during COVID-19; and third commonest cultured genus (1,262\/14098, 9.0%) after\n                      <jats:italic>Moraxella<\/jats:italic>\n                      sp. (1,360\/14,098, 9.6%) during the post-pandemic period. There were significant variations in the proportion of isolates with Haemophilus sp. (\u22127.9%,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001) and Pseudomonas sp. (+4.3%,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001) showing the highest change during COVID-19 compared to prior.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We found substantial differences in the number of isolate episodes identified. This could present important considerations for treatment of patients presenting with CAP during future pandemics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1816789","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T05:41:57Z","timestamp":1782798117000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of COVID-19 on sputum isolates and hospital outcomes among patients with pneumonia in Sheffield, United Kingdom: a retrospective cohort study"],"prefix":"10.3389","volume":"14","author":[{"given":"Patrick","family":"Copley","sequence":"first","affiliation":[{"name":"Department of Infection and Tropical Medicine, Royal Hallamshire Hospital, Sheffield Teaching Hospitals National Health Service Foundation Trust","place":["Sheffield, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Firima","sequence":"additional","affiliation":[{"name":"Department of Infection and Tropical Medicine, Royal Hallamshire Hospital, Sheffield Teaching Hospitals National Health Service Foundation Trust","place":["Sheffield, United Kingdom"]},{"name":"School of Medicine and Population Health, The University of Sheffield","place":["Sheffield, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"James","sequence":"additional","affiliation":[{"name":"Department of Infection and Tropical Medicine, Royal Hallamshire Hospital, Sheffield Teaching Hospitals National Health Service Foundation Trust","place":["Sheffield, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Saunders","sequence":"additional","affiliation":[{"name":"Department of Infection and Tropical Medicine, Royal Hallamshire Hospital, Sheffield Teaching Hospitals National Health Service Foundation Trust","place":["Sheffield, United Kingdom"]},{"name":"School of Medicine and Population Health, The University of Sheffield","place":["Sheffield, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Partridge","sequence":"additional","affiliation":[{"name":"The Florey Institute, University of Sheffield","place":["Sheffield, United Kingdom"]},{"name":"Department of Clinical Microbiology, Sheffield Teaching Hospitals NHS FT","place":["Sheffield, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joby","family":"Cole","sequence":"additional","affiliation":[{"name":"Department of Infection and Tropical Medicine, Royal Hallamshire Hospital, Sheffield Teaching Hospitals National Health Service Foundation Trust","place":["Sheffield, United Kingdom"]},{"name":"School of Medicine and Population Health, The University of Sheffield","place":["Sheffield, United Kingdom"]},{"name":"The Florey Institute, University of Sheffield","place":["Sheffield, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e2323035","DOI":"10.1001\/jamanetworkopen.2023.23035","article-title":"Outcomes among patients hospitalized with non-COVID-19 conditions before and during the COVID-19 pandemic in Alberta and Ontario, Canada","volume":"6","author":"McAlister","year":"2023","journal-title":"JAMA Netw Open"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"100489","DOI":"10.1016\/j.puhip.2024.100489","article-title":"The impact of the COVID-19 pandemic on non-COVID-associated mortality: a descriptive longitudinal study of UK data","volume":"7","author":"Makanjuola","year":"2024","journal-title":"Public Health Pract (Oxf)"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e001810","DOI":"10.1136\/bmjresp-2023-001810","article-title":"Impact of the COVID-19 pandemic on non-COVID-19 community-acquired pneumonia: a retrospective cohort study","volume":"10","author":"Lee","year":"2023","journal-title":"BMJ Open Respir Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"11038","DOI":"10.3390\/ijms241311038","article-title":"The global burden of community-acquired pneumonia in adults, encompassing invasive pneumococcal disease and the prevalence of its associated cardiovascular events, with a focus on Pneumolysin and macrolide antibiotics in pathogenesis and therapy","volume":"24","author":"Anderson","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref5","volume-title":"Overview of Community Acquired Pneumonia in Adults","author":"Ramirez","year":"2019"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S1473-3099(24)00176-2","article-title":"Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the global burden of disease study 2021","volume":"24","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"ref7","volume-title":"StatPearls","author":"Regunath","year":"2026"},{"key":"ref8","volume-title":"Pneumonia in Adults: Diagnosis and Management","year":"2023"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"Morens","year":"2008","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1324052","DOI":"10.1155\/2022\/1324052","article-title":"Changes in respiratory pathogens before and after the COVID-19 pandemic (2018-2021)","volume":"2022","author":"Kim","year":"2022","journal-title":"Biomed Res Int"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/antibiotics11030315","article-title":"Changing epidemiology of respiratory tract infection during COVID-19 pandemic","volume":"11","author":"Tang","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"12737","DOI":"10.1038\/s41598-024-62728-2","article-title":"Impact of the COVID-19 pandemic on Haemophilus influenzae infections in pediatric patients hospitalized with community acquired pneumonia","volume":"14","author":"Ai","year":"2024","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jinf.2022.10.019","article-title":"Changes of Haemophilus influenzae infection in children before and after the COVID-19 pandemic, Henan, China","volume":"86","author":"Zhou","year":"2022","journal-title":"J Infect"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e360","DOI":"10.1016\/S2589-7500(21)00077-7","article-title":"Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the invasive respiratory infection surveillance initiative: a prospective analysis of surveillance data","volume":"3","author":"Brueggemann","year":"2021","journal-title":"The Lancet Digital Health"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e582","DOI":"10.1016\/S2589-7500(23)00108-5","article-title":"Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS consortium","volume":"5","author":"Shaw","year":"2023","journal-title":"The Lancet Digital Health"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jamda.2017.09.028","article-title":"Examining the effects of age on health outcomes of chronic obstructive pulmonary disease: results from the genetic epidemiology of chronic obstructive pulmonary disease study and evaluation of chronic obstructive pulmonary disease longitudinally to identify predictive surrogate endpoints cohorts","volume":"18","author":"Parulekar","year":"2017","journal-title":"J Am Med Dir Assoc"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1183\/09059180.00003609","article-title":"Epidemiology of COPD","volume":"18","author":"Raherison","year":"2009","journal-title":"Eur Respir Rev"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1080\/1040841X.2020.1863330","article-title":"Non-typeable Haemophilus influenzae chronic colonization in chronic obstructive pulmonary disease (COPD)","volume":"47","author":"Short","year":"2021","journal-title":"Crit Rev Microbiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2001-1326-1-10","article-title":"Haemophilus influenzae and the lung (Haemophilus and the lung)","volume":"1","author":"King","year":"2012","journal-title":"Clin Transl Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"14734","DOI":"10.1038\/s41598-018-32973-3","article-title":"Patients with chronic obstructive pulmonary disease harbour a variation of Haemophilus species","volume":"8","author":"Osman","year":"2018","journal-title":"Sci Rep"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"ofae406","DOI":"10.1093\/ofid\/ofae406","article-title":"Predicting COVID 19\u2013associated pulmonary aspergillosis risk in low- and middle-income countries: a matched case-control study","volume":"11","author":"Moni","year":"2024","journal-title":"Open forum Infect Dis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.fbr.2021.09.003","article-title":"The rise in cases of mucormycosis, candidiasis and aspergillosis amidst COVID19","volume":"38","author":"Ghosh","year":"2021","journal-title":"Fungal Biol Rev"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"105039","DOI":"10.1016\/j.micinf.2022.105039","article-title":"COVID-19 and fungal infections: a double debacle","volume":"24","author":"Mina","year":"2022","journal-title":"Microbes Infect"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1007\/s00134-009-1482-8","article-title":"Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study","volume":"35","author":"Meersseman","year":"2009","journal-title":"Intensive Care Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/myc.13096","article-title":"COVID-19 associated pulmonary aspergillosis","volume":"63","author":"Koehler","year":"2020","journal-title":"Mycoses"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.2147\/IDR.S267238","article-title":"Coinfection of SARS-CoV-2 and other respiratory pathogens","volume":"13","author":"Ma","year":"2020","journal-title":"Infect Drug Resist"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s11606-016-3936-3","article-title":"The association between hospital capacity strain and inpatient outcomes in highly developed countries: a systematic review","volume":"32","author":"Eriksson","year":"2017","journal-title":"J Gen Intern Med"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1816789\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T05:41:58Z","timestamp":1782798118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1816789\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":28,"alternative-id":["10.3389\/fpubh.2026.1816789"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1816789","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"article-number":"1816789"}}